Andersen Karen V, Nikolajsen Lone, Daugaard Henrik, Andersen Niels T, Haraldsted Viggo, Søballe Kjeld
a 1 Departments of Orthopedic Surgery.
b 2 Anesthesiology , Aarhus University Hospital, Aarhus.
Acta Orthop. 2015;86(6):647-53. doi: 10.3109/17453674.2015.1081340. Epub 2015 Aug 27.
The effect of postoperative intra-articular bolus injections after total hip arthroplasty (THA) remains unclear. We tested the hypothesis that intra-articular bolus injections administered every 6 hours after surgery during the first 24 hours would significantly improve analgesia after THA.
80 patients undergoing THA received high-volume local infiltration analgesia (LIA; 200 mg ropivacaine and 30 mg ketorolac) followed by 4 intra-articular injections with either ropivacaine (100 mg) and ketorolac (15 mg) (the treatment group) or saline (the control group). The intra-articular injections were combined with 4 intravenous injections of either saline (treatment group) or 15 mg ketorolac (control group). All patients received morphine as patient-controlled analgesia (PCA). The primary outcome was consumption of intravenous morphine PCA and secondary outcomes were consumption of oral morphine, pain intensity, side effects, readiness for hospital discharge, length of hospital stay, and postoperative consumption of analgesics at 3, 6, and 12 weeks after surgery.
There were no statistically significant differences between the 2 groups regarding postoperative consumption of intravenous morphine PCA. Postoperative pain scores during walking were higher in the treatment group from 24-72 hours after surgery, but other pain scores were similar between groups. Time to readiness for hospital discharge was longer in the treatment group. Other secondary outcomes were similar between groups.
Postoperative intra-articular bolus injections of ropivacaine and ketorolac cannot be recommended as analgesic method after THA.
全髋关节置换术(THA)后关节腔内大剂量注射的效果仍不明确。我们检验了这样一个假设,即在术后头24小时内每6小时进行一次关节腔内大剂量注射,会显著改善THA后的镇痛效果。
80例行THA的患者接受大容量局部浸润镇痛(LIA;200毫克罗哌卡因和30毫克酮咯酸),随后进行4次关节腔内注射,注射药物为罗哌卡因(100毫克)和酮咯酸(15毫克)(治疗组)或生理盐水(对照组)。关节腔内注射联合4次静脉注射,静脉注射药物为生理盐水(治疗组)或15毫克酮咯酸(对照组)。所有患者均接受吗啡自控镇痛(PCA)。主要结局指标为静脉注射吗啡PCA的用量,次要结局指标包括口服吗啡用量、疼痛强度、副作用、出院准备情况、住院时间以及术后3周、6周和12周的镇痛药用量。
两组在术后静脉注射吗啡PCA的用量方面无统计学显著差异。术后24至72小时,治疗组行走时的疼痛评分较高,但两组的其他疼痛评分相似。治疗组达到出院准备状态的时间更长。两组的其他次要结局指标相似。
不推荐将罗哌卡因和酮咯酸术后关节腔内大剂量注射作为THA后的镇痛方法。